1
|
Tentori F, McCullough K, Kilpatrick RD,
Bradbury BD, Robinson BM, Kerr PG and Pisoni RL: High rates of
death and hospitalization follow bone fracture among hemodialysis
patients. Kidney Int. 85:166–173. 2014.PubMed/NCBI View Article : Google Scholar
|
2
|
Qi Q, Monier-Faugere MC, Geng Z and
Malluche HH: Predictive value of serum parathyroid hormone levels
for bone turnover in patients on chronic maintenance dialysis. Am J
Kidney Dis. 26:622–631. 1995.PubMed/NCBI View Article : Google Scholar
|
3
|
Salam S, Gallagher O, Gossiel F, Paggiosi
M, Khwaja A and Eastell R: Diagnostic accuracy of biomarkers and
imaging for bone turnover in renal osteodystrophy. J Am Soc
Nephrol. 29:1557–1565. 2018.PubMed/NCBI View Article : Google Scholar
|
4
|
Boyce BF and Xing L: Functions of
RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem
Biophys. 473:139–146. 2008.PubMed/NCBI View Article : Google Scholar
|
5
|
Rizzoli R, Biver E and Brennan-Speranza
TC: Nutritional intake and bone health. Lancet Diabetes Endocrinol.
9:606–621. 2021.PubMed/NCBI View Article : Google Scholar
|
6
|
Chen SC, Chung WS, Wu PY, Huang JC, Chiu
YW, Chang JM and Chen HC: Associations among Geriatric Nutrition
Risk Index, bone mineral density, body composition and handgrip
strength in patients receiving hemodialysis. Nutrition. 65:6–12.
2019.PubMed/NCBI View Article : Google Scholar
|
7
|
Lee H, Kim K, Ahn J, Lee DR, Lee JH and
Hwang SD: Association of nutritional status with osteoporosis,
sarcopenia, and cognitive impairment in patients on hemodialysis.
Asia Pac J Clin Nutr. 29:712–723. 2020.PubMed/NCBI View Article : Google Scholar
|
8
|
Yamada S, Arase H, Yoshida H, Kitamura H,
Tokumoto M, Taniguchi M, Hirakata H, Tsuruya K, Nakano T and
Kitazono T: Malnutrition-Inflammation complex syndrome (MICS) and
bone fractures and cardiovascular events in patients undergoing
hemodialysis: The Q-Cohort study. Kidney Med.
4(100408)2022.PubMed/NCBI View Article : Google Scholar
|
9
|
Tahimic CG, Wang Y and Bikle DD: Anabolic
effects of IGF-1 signaling on the skeleton. Front Endocrinol
(Lausanne). 4(6)2013.PubMed/NCBI View Article : Google Scholar
|
10
|
Bonjour JP: The dietary protein, IGF-I,
skeletal health axis. Horm Mol Biol Clin Investig. 28:39–53.
2016.PubMed/NCBI View Article : Google Scholar
|
11
|
Zanker CL and Cooke CB: Energy balance,
bone turnover, and skeletal health in physically active
individuals. Med Sci Sports Exerc. 36:1372–1381. 2004.PubMed/NCBI View Article : Google Scholar
|
12
|
Kovesdy CP and Kalantar-Zadeh K: Why is
protein-energy wasting associated with mortality in chronic kidney
disease? Semin Nephrol. 29:3–14. 2009.PubMed/NCBI View Article : Google Scholar
|
13
|
Ebeling PR, Peterson JM and Riggs BL:
Utility of type I procollagen propeptide assays for assessing
abnormalities in metabolic bone diseases. J Bone Miner Res.
7:1243–1250. 1992.PubMed/NCBI View Article : Google Scholar
|
14
|
Takahashi M, Kushida K, Nagano A and Inoue
T: Comparison of the analytical and clinical performance
characteristics of an N-MID versus an intact osteocalcin
immunoradiometric assay. Clin Chim Acta. 294:67–76. 2000.PubMed/NCBI View Article : Google Scholar
|
15
|
Okabe R, Nakatsuka K, Inaba M, Miki T,
Naka H, Masaki H, Moriguchi A and Nishizawa Y: Clinical evaluation
of the Elecsys beta-CrossLaps serum assay, a new assay for
degradation products of type I collagen C-tlopeptides. Clin Chem.
47:1410–1414. 2001.PubMed/NCBI
|
16
|
Hayes AF and Cai L: Using
heteroskedasticity-consistent standard error estimators in OLS
regression: An introduction and software implementation. Behav Res
Methods. 39:709–722. 2007.PubMed/NCBI View Article : Google Scholar
|
17
|
Jia T, Gama Axelsson T, Heimbürger O,
Bárány P, Lindholm B, Stenvinkel P and Qureshi AR: IGF-1 and
Survival in ESRD. Clin J Am Soc Nephrol. 9:120–127. 2014.PubMed/NCBI View Article : Google Scholar
|
18
|
Haarhaus M and Evenepoel P: European Renal
Osteodystrophy (EUROD) workgroup; Chronic Kidney Disease Mineral
and Bone Disorder (CKD-MBD) working group of the European Renal
Association–European Dialysis and Transplant Association
(ERA-EDTA). Differentiating the causes of adynamic bone in advanced
chronic kidney disease informs osteoporosis treatment. Kidney Int.
100:546–558. 2021.PubMed/NCBI View Article : Google Scholar
|
19
|
Manolagas SC: Birth and death of bone
cells: Basic regulatory mechanisms and implications for the
pathogenesis and treatment of osteoporosis. Endocr Rev. 21:115–137.
2000.PubMed/NCBI View Article : Google Scholar
|
20
|
Gonzalez EA, Sachdeva A, Oliver DA and
Martin KJ: Vitamin D insufficiency and deficiency in chronic kidney
disease. A single center observational study. Am J Nephrol.
24:503–510. 2004.PubMed/NCBI View Article : Google Scholar
|
21
|
Jørgensen HS, Winther S, Bøttcher M, Hauge
EM, Rejnmark L, Svensson M and Ivarsen P: Bone turnover markers are
associated with bone density, but not with fracture in end stage
kidney disease: A cross-sectional study. BMC Nephrol.
18(284)2017.PubMed/NCBI View Article : Google Scholar
|
22
|
Lv J, Xie W, Wang S, Zhu Y, Wang Y, Zhang
P and Chen J: Associated factors of osteoporosis and vascular
calcification in patients awaiting kidney transplantation. Int Urol
Nephrol: Apr 24, 2023 (Epub ahead of print).
|
23
|
Brandenburg VM and Floege J: Adynamic bone
disease-bone and beyond. NDT Plus. 1:135–147. 2008.PubMed/NCBI View Article : Google Scholar
|
24
|
Li D, Zhang L, Zuo L, Jin CG, Li WG and
Chen JB: Association of CKD-MBD markers with all-cause mortality in
prevalent hemodialysis patients: A cohort study in beijing. PLoS
One. 12(e0168537)2017.PubMed/NCBI View Article : Google Scholar
|
25
|
Leavey SF, McCullough K, Hecking E,
Goodkin D, Port FK and Young EW: Body mass index and mortality in
‘healthier’ as compared with ‘sicker’ haemodialysis patients:
Results from the dialysis outcomes and practice patterns study
(DOPPS). Nephrol Dial Transplant. 16:2386–2394. 2001.PubMed/NCBI View Article : Google Scholar
|